Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:14 AM ET

Sponsor Check › Person

No photo found yet (own website and image search run after this page is viewed)

David Jorden

Named as an officer, director or promoter on SEC Form D filings · TX, MD · Jul 9, 2009 → Aug 4, 2025

4deals (issuers)

$56.8Mreported sold

165investors

32Form D filings

2009–2025years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

David Jorden is listed as an executive officer and director on 32 SEC Form D filings by 4 issuers between Jul 2009 and Aug 2025: Nuo Therapeutics, Inc. (Houston, TX — other health care — 2010–2025; $21M reported sold to 26 investors), PLx Pharma Inc. (Sparta, NJ — pharmaceuticals — 2017; $18.2M reported sold to 37 investors), PLX PHARMA INC. (Houston, TX — pharmaceuticals — 2009–2016; $9M reported sold to 51 investors) and NANOSPECTRA BIOSCIENCES INC (Houston, TX — other health care — 2013–2023; $8.61M reported sold to 51 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $56.8M sold in total.

Listed alongside C. Eric Winzer (11 shared filings), Glenn Goodrich (9 shared filings), Patrick Pace (9 shared filings), Peter Clausen (9 shared filings), Scott Pittman (9 shared filings) and 41 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.

All 4 issuers belong to the sponsor group Plx Pharma (4 issuers, $26.2M reported sold, 2009–2025).

What this means A sponsor group is one team that sets up a new company for each deal. Plx Pharma has 4 companies on file and $26.2M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 9 court cases matching the name, 14 bankruptcy cases matching the name listed in Key records below.

What this means 23 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 32 public filings for David Jorden and found 12 differences, 1 worth asking the sponsor about: 6 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for David Jorden has not run yet — it is joining a line of 10,699 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

9 cases: 2 open, 2 dismissed, 3 closed (disposition not in docket feed), 2 judgment

Jorden v. Davol, Inc. open

District Court, S.D. Ohio · No. 2:21-cv-02475 · Filed May 13, 2021

Role of Jorden: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in OH (not a filing state)

Jorden v. Prestige Financial Services, Inc. dismissed

District Court, N.D. Indiana · No. 2:18-cv-00081 · Filed Feb 27, 2018 · Closed Jan 7, 2019 · Nature of suit: 480 Consumer Credit · Cause: 47:227 Telephone Consumer Protection Act

Role of Jorden: Plaintiff · Outcome: Terminated 2019-01-07 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in IN (not a filing state)

Jorden v. Janssen Research & Development, LLC closed

District Court, E.D. Louisiana · No. 2:16-cv-03306 · Filed Apr 18, 2016 · Closed Mar 17, 2022 · Nature of suit: 367 Health care / pharm

Role of Jorden: Plaintiff · Outcome: Terminated 2022-03-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in LA (not a filing state)

Preservation Mgmt, Inc. - Briarcliff Summit v. Jorden closed

District Court, N.D. Georgia · No. 1:15-cv-03594 · Filed Oct 9, 2015 · Closed Nov 12, 2015 · Nature of suit: 230 Rent, lease, ejectment

Role of Jorden: Defendant · Outcome: Terminated 2015-11-12 — FJC Integrated Database disposition: Remanded to state court Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in GA (not a filing state)

Union Mortgage Corpo v. Jorden judgment

District Court, N.D. Illinois · No. 1:91-cv-01967 · Filed Apr 3, 1991 · Closed Oct 2, 1991 · Nature of suit: 220 Foreclosure

Role of Jorden: Defendant · Outcome: Terminated 1991-10-02 — FJC Integrated Database disposition: Judgment on default; judgment for plaintiff Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in IL (not a filing state)

A-L ASSOCIATES, INC. v. JORDEN dismissed

District Court, District of Columbia · No. 1:91-cv-00197 · Filed Jan 29, 1991 · Closed Jun 11, 1991 · Nature of suit: 190 Other contract actions

Role of JORDEN: Defendant · Outcome: Terminated 1991-06-11 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in DC (not a filing state)

Victoria Mortgage Co v. Jorden judgment

District Court, N.D. Illinois · No. 1:90-cv-04557 · Filed Aug 7, 1990 · Closed Oct 24, 1990 · Nature of suit: 220 Foreclosure

Role of Jorden: Defendant · Outcome: Terminated 1990-10-24 — FJC Integrated Database disposition: Judgment on default; judgment for plaintiff Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in IL (not a filing state)

Jorden v. General Motors Corp open

District Court, M.D. Pennsylvania · No. 3:89-mc-00224 · Filed Sep 6, 1989

Role of Jorden: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in PA (not a filing state)

Jorden v. Armco Inc. Noncontributory Pension Plan closed

District Court, S.D. West Virginia · No. 2:82-cv-02525 · Filed Oct 29, 1982 · Closed Oct 29, 1982

Role of Jorden: Plaintiff · Outcome: Terminated 1982-10-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in WV (not a filing state)

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched David Jorden..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

14 cases: 6 open, 8 closed (disposition not in docket feed)

David Ray Elizondo, Jr and Jorden Nicole Elizondo open

United States Bankruptcy Court, D. Oregon · No. 26-62077 · Filed Jul 28, 2026

Role of David Ray Elizondo, Jr and Jorden Nicole Elizondo: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in OR (not a filing state)

Christopher Obrian Edwards and Jorden Rheanna Edwards open

United States Bankruptcy Court, E.D. Texas · No. 26-40778 · Filed Mar 5, 2026

Role of Christopher Obrian Edwards and Jorden Rheanna Edwards: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in the person's filing state (TX)

Bryan Hanson and Jorden Hanson open

United States Bankruptcy Court, W.D. North Carolina · No. 26-10041 · Filed Feb 21, 2026

Role of Bryan Hanson and Jorden Hanson: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in NC (not a filing state)

Nathan Sean Adams and Jorden Aubrie Adams open

United States Bankruptcy Court, N.D. Alabama · No. 25-41231 · Filed Sep 15, 2025

Role of Nathan Sean Adams and Jorden Aubrie Adams: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in AL (not a filing state)

DAVID JORDEN GOSNELL and KAITLIN JENNA MCDONALD closed

United States Bankruptcy Court, D. Arizona · No. 2:24-bk-06014 · Filed Jul 24, 2024 · Closed Dec 16, 2024

Role of DAVID JORDEN GOSNELL and KAITLIN JENNA MCDONALD: Debtor · Outcome: Case closed 2024-12-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); first name matches; 2 people with this name in Form D filings; court in AR (not a filing state)

Joseph Daniel Brady and Jorden Brooke Brady open

United States Bankruptcy Court, E.D. Tennessee · No. 3:23-bk-31582 · Filed Sep 8, 2023

Role of Joseph Daniel Brady and Jorden Brooke Brady: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in TN (not a filing state)

Robert Chandler and Jorden Chandler open

United States Bankruptcy Court, M.D. Alabama · No. 23-31604 · Filed Aug 11, 2023

Role of Robert Chandler and Jorden Chandler: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in AL (not a filing state)

Robert Wilkinson and Jorden M Wilkinson closed

United States Bankruptcy Court, D. Nebraska · No. 21-40060 · Filed Jan 21, 2021 · Closed Jun 8, 2021

Role of Robert Wilkinson and Jorden M Wilkinson: Debtor · Outcome: Case closed 2021-06-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption

AmeriCash Loans, L.L.C. v. Jorden closed

United States Bankruptcy Court, N.D. Illinois · No. 16-00226 · Filed Mar 31, 2016 · Closed Jul 15, 2016

Role of Jorden: Defendant · Outcome: Case closed 2016-07-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in IL (not a filing state)

FIA Card Services v. Jorden closed

United States Bankruptcy Court, E.D. Missouri · No. 07-04447 · Filed Oct 5, 2007 · Closed Dec 11, 2007

Role of Jorden: Defendant · Outcome: Case closed 2007-12-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); surname only in the caption; court in MO (not a filing state)

David A. Jorden closed

United States Bankruptcy Court, N.D. Ohio · No. 00-41586 · Filed Jun 1, 2000 · Closed Nov 17, 2000

Role of David A. Jorden: Debtor · Outcome: Case closed 2000-11-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); first name matches; 2 people with this name in Form D filings; court in OH (not a filing state)

David L Jorden and Brenda J Jorden closed

United States Bankruptcy Court, M.D. Pennsylvania · No. 1:99-bk-05114 · Filed Dec 6, 1999 · Closed Mar 23, 2000

Role of David L Jorden and Brenda J Jorden: Debtor · Outcome: Case closed 2000-03-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); first name matches; 2 people with this name in Form D filings; court in PA (not a filing state)

DAVID A. JORDEN closed

United States Bankruptcy Court, D. Arizona · No. 0:99-bk-00321 · Filed Mar 31, 1999 · Closed Aug 16, 1999

Role of DAVID A. JORDEN: Debtor · Outcome: Case closed 1999-08-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); first name matches; 2 people with this name in Form D filings; court in AR (not a filing state)

David W. Jorden and Bernadette Brown Jorden closed

United States Bankruptcy Court, E.D. Louisiana · No. 86-13686 · Filed Sep 24, 1986 · Closed Jan 13, 1987

Role of David W. Jorden and Bernadette Brown Jorden: Debtor · Outcome: Case closed 1987-01-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 46 federal dockets); first name matches; 2 people with this name in Form D filings; court in LA (not a filing state)

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for David Jorden — 1 worth asking about (compared 32 filings on Oct 24, 2026)

Worth asking · Jan 6, 2009 – Mar 11, 2016

6 Form Ds were filed more than 15 days after the first sale

Form D filed 344 days after the first sale — PLX PHARMA INC. · Form D filed 66 days after the first sale — PLX PHARMA INC. · Form D filed 184 days after the first sale — PLX PHARMA INC. · Form D filed 17 days after the first sale — PLX PHARMA INC. · Form D filed 41 days after the first sale — PLX PHARMA INC. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 19, 2013 ↗PLX PHARMA INC. — PartnerFacts page ↗Form D · Oct 5, 2011 ↗Form D · Jul 9, 2009 ↗

Sources

Form D · Mar 19, 2013 ↗ (Mar 19, 2013)
PLX PHARMA INC. — PartnerFacts page ↗ (Mar 11, 2016)
Form D · Oct 5, 2011 ↗ (Oct 5, 2011)
Form D · Jul 9, 2009 ↗ (Jul 9, 2009)
Form D · Mar 11, 2016 ↗ (Mar 11, 2016)
Form D · Jul 8, 2013 ↗ (Jul 8, 2013)
Form D · Aug 9, 2010 ↗ (Aug 9, 2010)

Note · Dec 10, 2013 – May 20, 2016

David Jorden's role changed at Nuo Therapeutics, Inc.: director → executive officer, director

The Dec 10, 2013 filing lists David Jorden as director; the May 20, 2016 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Dec 10, 2013 ↗Form D · May 20, 2016 ↗David Jorden — PartnerFacts page ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Dec 10, 2013 ↗ (Dec 10, 2013)
Form D · May 20, 2016 ↗ (May 20, 2016)
David Jorden — PartnerFacts page ↗
Nuo Therapeutics, Inc. — PartnerFacts page ↗ (Aug 4, 2025)

Note · Jul 8, 2013 – Mar 11, 2016

David Jorden's role changed at PLX PHARMA INC.: director → executive officer

The Jul 8, 2013 filing lists David Jorden as director; the Mar 11, 2016 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jul 8, 2013 ↗Form D · Mar 11, 2016 ↗David Jorden — PartnerFacts page ↗PLX PHARMA INC. — PartnerFacts page ↗

Sources

Form D · Jul 8, 2013 ↗ (Jul 8, 2013)
Form D · Mar 11, 2016 ↗ (Mar 11, 2016)
David Jorden — PartnerFacts page ↗
PLX PHARMA INC. — PartnerFacts page ↗ (Mar 11, 2016)

Note · Jul 22, 2010 – Mar 15, 2023

10 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — NANOSPECTRA BIOSCIENCES INC (latest filing Mar 15, 2023) · No amendment in the last 12 months on an offering that may still be open — NANOSPECTRA BIOSCIENCES INC (latest filing Aug 5, 2021) · No amendment in the last 12 months on an offering that may still be open — NANOSPECTRA BIOSCIENCES INC (latest filing Feb 10, 2017) · No amendment in the last 12 months on an offering that may still be open — Nuo Therapeutics, Inc. (latest filing May 20, 2016) · No amendment in the last 12 months on an offering that may still be open — PLX PHARMA INC. (latest filing Mar 11, 2016) · and 5 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Mar 15, 2023 ↗NANOSPECTRA BIOSCIENCES INC — PartnerFacts page ↗Form D/A · Aug 5, 2021 ↗Form D · Feb 10, 2017 ↗

Sources

Form D · Mar 15, 2023 ↗ (Mar 15, 2023)
NANOSPECTRA BIOSCIENCES INC — PartnerFacts page ↗ (Mar 15, 2023)
Form D/A · Aug 5, 2021 ↗ (Aug 5, 2021)
Form D · Feb 10, 2017 ↗ (Feb 10, 2017)
Form D · May 20, 2016 ↗ (May 20, 2016)
Nuo Therapeutics, Inc. — PartnerFacts page ↗ (Aug 4, 2025)
Form D · Mar 11, 2016 ↗ (Mar 11, 2016)
PLX PHARMA INC. — PartnerFacts page ↗ (Mar 11, 2016)

Note · Jul 9, 2009 – Apr 22, 2010

David Jorden is written 2 different ways on the filings

listed as "David Jorden" on 25 filings (from Jul 9, 2009), and "David E. Jorden" on 7 filings (from Apr 22, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 9, 2009 ↗Form D · Apr 22, 2010 ↗David Jorden — PartnerFacts page ↗

Sources

Note · Apr 22, 2010 – May 6, 2022

Industry group changed between filings — Nuo Therapeutics, Inc.

"Biotechnology" (Apr 22, 2010 to Jun 12, 2018); then "Other Health Care" (May 6, 2022 to Aug 4, 2025).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 22, 2010 ↗Form D · May 6, 2022 ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Apr 22, 2010 ↗ (Apr 22, 2010)
Form D · May 6, 2022 ↗ (May 6, 2022)
Nuo Therapeutics, Inc. — PartnerFacts page ↗ (Aug 4, 2025)

Note · Apr 27, 2009 – Feb 19, 2013

Same name, different state: "David E. Jorden" (TX) is a separate record

This page covers filings where the address state is TX or MD. A separate record, "David E. Jorden" with address state TX, is listed on 5 filings — most recently by Acer Therapeutics Inc. (Feb 19, 2013). Both records have filings in the same period (Jul 9, 2009 to Feb 19, 2013).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

David E. Jorden (TX) — PartnerFacts page ↗Form D · Feb 19, 2013 ↗Acer Therapeutics Inc. — PartnerFacts page ↗David Jorden (TX,MD) — this page ↗

Sources

David E. Jorden (TX) — PartnerFacts page ↗ (Feb 19, 2013)
Form D · Feb 19, 2013 ↗ (Feb 19, 2013)
Acer Therapeutics Inc. — PartnerFacts page ↗ (Dec 5, 2022)
David Jorden (TX,MD) — this page ↗ (Aug 4, 2025)

Note · Jun 12, 2018 – May 6, 2022

Address moved from Gaithersburg, MD to Houston, TX — Nuo Therapeutics, Inc.

The people listed on the Jun 12, 2018 filing give Gaithersburg, MD; on the May 6, 2022 filing they give Houston, TX.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jun 12, 2018 ↗Form D · May 6, 2022 ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Jun 12, 2018 ↗ (Jun 12, 2018)
Form D · May 6, 2022 ↗ (May 6, 2022)
Nuo Therapeutics, Inc. — PartnerFacts page ↗ (Aug 4, 2025)

Note · Apr 22, 2010 – Oct 19, 2010

Address moved from Rockville, MD to Gaithersburg,, MD — Nuo Therapeutics, Inc.

The people listed on the Apr 22, 2010 filing give Rockville, MD; on the Oct 19, 2010 filing they give Gaithersburg,, MD.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Apr 22, 2010 ↗Form D · Oct 19, 2010 ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Apr 22, 2010 ↗ (Apr 22, 2010)
Form D · Oct 19, 2010 ↗ (Oct 19, 2010)
Nuo Therapeutics, Inc. — PartnerFacts page ↗ (Aug 4, 2025)

Note · Jul 9, 2009 – Aug 4, 2025

David Jorden is listed with 2 different address states: TX, MD

TX on 23 filings (Jul 9, 2009 to Aug 4, 2025); MD on 9 filings (Apr 22, 2010 to Jun 12, 2018).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 9, 2009 ↗Form D · Apr 22, 2010 ↗

Sources

Form D · Jul 9, 2009 ↗ (Jul 9, 2009)
Form D · Apr 22, 2010 ↗ (Apr 22, 2010)

Note · Apr 22, 2010 – Jun 12, 2018

Reported revenue range changed between filings — Nuo Therapeutics, Inc.

"$1,000,001 - $5,000,000" (Apr 22, 2010); then "$5,000,001 - $25,000,000" (Feb 15, 2012); then "Not Applicable" (May 20, 2016); then "Decline to Disclose" (Jun 12, 2018).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 22, 2010 ↗Form D · Feb 15, 2012 ↗Form D · May 20, 2016 ↗Form D · Jun 12, 2018 ↗

Sources

Form D · Apr 22, 2010 ↗ (Apr 22, 2010)
Form D · Feb 15, 2012 ↗ (Feb 15, 2012)
Form D · May 20, 2016 ↗ (May 20, 2016)
Form D · Jun 12, 2018 ↗ (Jun 12, 2018)
Nuo Therapeutics, Inc. — PartnerFacts page ↗ (Aug 4, 2025)

Note · Jul 9, 2009 – Mar 19, 2013

Reported revenue range changed between filings — PLX PHARMA INC.

"$1 - $1,000,000" (Jul 9, 2009); then "$1,000,001 - $5,000,000" (Oct 5, 2011); then "$1 - $1,000,000" (Mar 19, 2013).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 9, 2009 ↗Form D · Oct 5, 2011 ↗Form D · Mar 19, 2013 ↗PLX PHARMA INC. — PartnerFacts page ↗

Sources

Form D · Jul 9, 2009 ↗ (Jul 9, 2009)
Form D · Oct 5, 2011 ↗ (Oct 5, 2011)
Form D · Mar 19, 2013 ↗ (Mar 19, 2013)
PLX PHARMA INC. — PartnerFacts page ↗ (Mar 11, 2016)

What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

3 of 31 offerings report sales commissions totalling $1,723,512; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Aug 4, 2025 D Nuo Therapeutics, Inc. File 021-553598	$0	$0	$0	None listed on this filing	EDGAR ↗
Sep 23, 2024 D Nuo Therapeutics, Inc. File 021-524645	$0	$0	$0	None listed on this filing	EDGAR ↗
May 22, 2024 D Nuo Therapeutics, Inc. File 021-513970	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 22, 2023 D Nuo Therapeutics, Inc. File 021-500556	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 8, 2023 D Nuo Therapeutics, Inc. File 021-489113	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 15, 2023 D NANOSPECTRA BIOSCIENCES INC File 021-475955	$0	$0	$0	None listed on this filing	EDGAR ↗
May 19, 2022 D Nuo Therapeutics, Inc. File 021-446304	$0	$0	$0	None listed on this filing	EDGAR ↗
May 6, 2022 D Nuo Therapeutics, Inc. File 021-444862	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 5, 2021 D/A NANOSPECTRA BIOSCIENCES INC File 021-375044	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 12, 2018 D Nuo Therapeutics, Inc. File 021-314431	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 28, 2017 D PLx Pharma Inc. File 021-289624	$1,191,512	$0	$0 No proceeds are proposed to be used for payments to such persons other than ordinary salary expenses that may be paid out of working capital.	Raymond James & Associates, Inc. BrokerCheck CRD 705 ↗ Janney Montgomery Scott LLC BrokerCheck CRD 463 ↗	EDGAR ↗
Feb 10, 2017 D NANOSPECTRA BIOSCIENCES INC File 021-280450	$0	$0	$0	None listed on this filing	EDGAR ↗
May 20, 2016 D Nuo Therapeutics, Inc. File 021-263573	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 11, 2016 D PLX PHARMA INC. File 021-259059	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 15, 2015 D NANOSPECTRA BIOSCIENCES INC File 021-253113	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 29, 2014 D NANOSPECTRA BIOSCIENCES INC File 021-223887	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 10, 2013 D Nuo Therapeutics, Inc. File 021-207744	$240,000 (est.)	$0	$0	BTIG, LLC BrokerCheck CRD 122225 ↗	EDGAR ↗
Jul 8, 2013 D PLX PHARMA INC. File 021-199168	$0	$0	$0 (est.)	None listed on this filing	EDGAR ↗
Jun 17, 2013 D NANOSPECTRA BIOSCIENCES INC File 021-198131	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 4, 2013 D NANOSPECTRA BIOSCIENCES INC File 021-197405	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 4, 2013 D NANOSPECTRA BIOSCIENCES INC File 021-197406	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 19, 2013 D PLX PHARMA INC. File 021-193567	$0	$0	$0 (est.)	None listed on this filing	EDGAR ↗
Feb 15, 2012 D Nuo Therapeutics, Inc. File 021-173531	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 5, 2011 D PLX PHARMA INC. File 021-166758	$0	$0	$0	None listed on this filing	EDGAR ↗
Jul 26, 2011 D Nuo Therapeutics, Inc. File 021-163473	$0	$0	$0	None listed on this filing	EDGAR ↗
Jul 26, 2011 D Nuo Therapeutics, Inc. File 021-163474	$0	$0	$0	None listed on this filing	EDGAR ↗
May 4, 2011 D Nuo Therapeutics, Inc. File 021-159274	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 19, 2010 D Nuo Therapeutics, Inc. File 021-149299	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 9, 2010 D PLX PHARMA INC. File 021-146099	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 22, 2010 D Nuo Therapeutics, Inc. File 021-140962	$292,000	$0	$0	MAXIM GROUP LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jul 9, 2009 D PLX PHARMA INC. File 021-65821	$0	$0	$0	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named David Jorden on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Other Health Care · group: Plx Pharma

Nuo Therapeutics, Inc.

Houston, TX · Apr 22, 2010 → Aug 4, 2025 · 16 filings

Aug 4, 2025 · D · $791,418 sold of $791,418 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Sep 23, 2024 · D · $849,125 sold of $849,125 · 10 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
May 22, 2024 · D · $650,875 sold of $650,875 · 11 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Dec 22, 2023 · D · $962,500 sold of $962,500 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Aug 8, 2023 · D · $1,035,000 sold of $1,035,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
May 19, 2022 · D · $407,757 sold of $407,757 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
May 6, 2022 · D · $3,550,000 sold of $3,550,000 · 26 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 12, 2018 · D · $500,000 sold of $500,000 · 1 investors · min. $500,000 · role: Executive Officer, Director EDGAR ↗
May 20, 2016 · D · $7,500,000 sold of $10,500,000 · 25 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Dec 10, 2013 · D · $3,000,000 sold of $3,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
Feb 15, 2012 · D · $21,000,000 sold of $21,000,000 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 26, 2011 · D · $1,300,000 sold of $1,300,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 26, 2011 · D · $600,000 sold of $600,000 · 4 investors · min. $100,000 · role: Director EDGAR ↗
May 4, 2011 · D · $325,000 sold of $325,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
Oct 19, 2010 · D · $146,853 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Apr 22, 2010 · D · $3,650,000 sold of $3,650,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $21M from 26 investors (100% of the $791K target) as of the latest filing. David is listed as executive officer, director on 16 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Plx Pharma

NANOSPECTRA BIOSCIENCES INC

Houston, TX · Jun 4, 2013 → Mar 15, 2023 · 9 filings

Mar 15, 2023 · D · $6,066,104 sold of $10,066,119 · 51 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Aug 5, 2021 · D/A · $8,614,644 sold of $11,264,664 · 41 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Sep 8, 2020 · D · $6,857,358 sold of $11,264,664 · 40 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Feb 10, 2017 · D · $2,026,497 sold of $4,166,391 · 19 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Dec 15, 2015 · D · $945,995 sold of $1,200,000 · 15 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Aug 29, 2014 · D · $800,000 sold of $800,000 · 15 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 17, 2013 · D · $525,000 sold of $700,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 4, 2013 · D · $1,572,500 sold of $1,572,500 · 12 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 4, 2013 · D · $849,999 sold of $849,999 · 14 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $8.61M from 51 investors (86% of the $10.1M target) as of the latest filing. David is listed as executive officer, director on 9 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pharmaceuticals · group: Plx Pharma

PLx Pharma Inc.

Sparta, NJ · Jun 28, 2017

Jun 28, 2017 · D · $18,191,869 sold of $18,191,869 · 37 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $18.2M from 37 investors (100% of the $18.2M target) as of the latest filing. David is listed as executive officer.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals · group: Plx Pharma

PLX PHARMA INC.

Houston, TX · Jul 9, 2009 → Mar 11, 2016 · 6 filings

Mar 11, 2016 · D · $1,297,000 sold of $2,000,000 · 27 investors · min. No minimum reported · role: Executive Officer (CFO, Secretary) EDGAR ↗
Jul 8, 2013 · D · $9,000,000 sold of $9,000,000 · 51 investors · min. $25,000 · role: Director EDGAR ↗
Mar 19, 2013 · D · $8,273,297 sold of $8,273,297 · 33 investors · min. $25,000 · role: Director EDGAR ↗
Oct 5, 2011 · D · $2,893,965 sold of $7,000,000 · 22 investors · min. $25,000 · role: Director EDGAR ↗
Aug 9, 2010 · D · $2,000,020 sold of $6,000,000 · 21 investors · min. $25,000 · role: Director EDGAR ↗
Jul 9, 2009 · D · $3,106,961 sold of $3,106,961 · 26 investors · min. $24,960 · role: Director EDGAR ↗

Raised $9M from 51 investors (100% of the $2M target) as of the latest filing. David is listed as executive officer, director on 6 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

David E. Jorden — TX, 1 issuer, Apr 27, 2009 → Feb 19, 2013 · no shared issuer

People around David 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

No photo found yet (own website and image search run after this page is viewed)

Person

C. Eric Winzer

Director · 11 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Patrick Pace

Executive Officer, Director · 9 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Glenn Goodrich

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Scott Pittman

Director · 9 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Peter Clausen

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Paul Mintz

Director · 8 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Martin P. Rosendale

Director, Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

ANDREW S. MASLAN

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Gary Mossman

Executive Officer, Director · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

MARK T. MCLOUGHLIN

Director · 6 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Bradley Nyberg

Director · 6 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

David Anderson

Director · 5 shared filings (1 issuer) · also on 7 other issuers

David Anderson is on 8 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Tim Black

Director · 5 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Lenard M. Lichtenberger

Director · 5 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Eric C. Winzer

Director · 5 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Blair Shamel

Director · 5 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

David Bristol

Director · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Michael Valentino

Director, Executive Officer · 4 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

James S. Benson

Director · 4 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Ronald R. Zimmerman

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Jennifer West

Director · 4 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

CRAIG B. MENDELSOHN

Director · 4 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

KEITH N. STEPHEN

Director · 4 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Joseph Del Guercio

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Joseph Del Guercio is on 6 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Stephen Keith

Director · 3 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Kevin P. Smith

Director · 3 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

BENSON S. JAMES

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Richard Kent

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Richard Kent is on 7 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Patrick P. Vanek

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

LYLE A. HOHNKE

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Natasha Giordano

Executive Officer, Director · 2 shared filings (2 issuers) · also on 4 other issuers

Natasha Giordano is on 6 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Alexander F. Seelenberger

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Kirk Calhoun

Director · 2 shared filings (2 issuers)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Gary Balkema

Director · 2 shared filings (2 issuers)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

John W. Hadden II

Director · 2 shared filings (2 issuers)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

LAWRENCE S ATINSKY

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Steven A. Shallcross

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

CRAIG B. MENDELSON

Director · 1 shared filing (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

MARK T. MCLOUGHUN

Director · 1 shared filing (1 issuer)

Listed on the same filings as David Jorden. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

David P. Luci

Director · 1 shared filing (1 issuer) · also on 4 other issuers

David P. Luci is on 5 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Sponsor group

Plx Pharma

4 issuers · 41 filings · $26.2M reported sold · 2009–2025

NT Nuo Therapeutics, Inc. Other Health Care · $21M sold · 2010 · listed
NB NANOSPECTRA BIOSCIENCES INC Other Health Care · $8.61M sold · 2010 · listed
PP PLx Pharma Inc. Pharmaceuticals · $18.2M sold · 2010 · listed
PP PLX PHARMA INC. Pharmaceuticals · $9M sold · 2009 · listed

One team, 4 deal companies. David Jorden is listed on 4 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name David Jorden.

Same business address

2 other issuers file from the same address

CAVU Biotherapies, Inc. Houston, TX · 2017
Vapogenix, Inc. Houston, TX · 2014

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to David Jorden by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers David Jorden is listed on: none on file. No website or social profile named in PLx Pharma Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #205,707 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Sparta, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when David Jorden appears on a new Form D, or when a court case or SEC action is matched to them. See plans →

David Jorden

The short version

What the community is saying

Key records

1. Lawsuits

2. Regulatory actions

3. Bankruptcies

4. Differences between public sources

6 Form Ds were filed more than 15 days after the first sale

David Jorden's role changed at Nuo Therapeutics, Inc.: director → executive officer, director

David Jorden's role changed at PLX PHARMA INC.: director → executive officer

10 offerings have no amendment in the last 12 months and may still be open

David Jorden is written 2 different ways on the filings

Industry group changed between filings — Nuo Therapeutics, Inc.

Same name, different state: "David E. Jorden" (TX) is a separate record

Address moved from Gaithersburg, MD to Houston, TX — Nuo Therapeutics, Inc.

Address moved from Rockville, MD to Gaithersburg,, MD — Nuo Therapeutics, Inc.

David Jorden is listed with 2 different address states: TX, MD

Reported revenue range changed between filings — Nuo Therapeutics, Inc.

Reported revenue range changed between filings — PLX PHARMA INC.

5. Money to insiders

Deals 4

People around David 40

The team behind the deals

2 other issuers file from the same address

Registrations and other filings

Adviser registration (Form ADV)

Other offering types (Regulation A and Regulation Crowdfunding)

Public profiles and social

Look further

Social and web

Courts

Securities regulators

Business registries

Change history

Request a correction

Add a response

Monitor this person